Back to Journals » Infection and Drug Resistance » Volume 14

The lncRNA CCAT2 Rs6983267 G Variant Contributes to Increased Sepsis Susceptibility in a Southern Chinese Population

Authors Wu Z, Liang Y , Zuo Y, Xu Y, Mai H , Pi L, Che D, Gu X

Received 23 March 2021

Accepted for publication 21 May 2021

Published 4 August 2021 Volume 2021:14 Pages 2969—2976

DOI https://doi.org/10.2147/IDR.S311717

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Héctor Mora-Montes



Zhiyuan Wu,1,* Yufeng Liang,1,* Yunlong Zuo,1,* Yufen Xu,2 Hanran Mai,2 Lei Pi,2 Di Che,2 Xiaoqiong Gu2

1Pediatric Intensive Care Unit. Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of China; 2Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Xiaoqiong Gu; Di Che
Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510623, People’s Republic of China
Tel/Fax +86-20-38076561
; +86-20-38076562
Email [email protected]; [email protected]

Purpose: Accumulating evidence demonstrates that genetic susceptibility genes can be used as biomarkers to assess sepsis susceptibility, and genetic variation is associated with susceptibility and clinical outcomes in patients with sepsis and inflammatory disease. Although studies have shown that the lncRNA CCAT2 is involved in inflammatory diseases, it remains unclear whether CCAT2 gene polymorphisms are associated with susceptibility to inflammatory diseases, such as sepsis, in children.
Methods: We genotyped the rs6983267 CCAT2 polymorphism in 474 cases (pediatric sepsis) and 678 controls using TaqMan methods, and odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of associations.
Results: Our results indicate that the rs6983267 T > G polymorphism is significantly associated with an increased risk of sepsis in children (TG and TT: adjusted OR = 1.311, 95% CI = 1.016– 1.743, GG and TT: adjusted OR = 1.444, 95% CI = 1.025– 2.034 dominant model: GG/TG vs TT adjusted OR = 1.362, 95% CI = 1.055– 1.756). Furthermore, the risk effect was more pronounced in children younger than 60 months who were male and who had sepsis.
Conclusion: We found that the CCAT2 gene polymorphism rs6983267 T > G may be associated with an increased risk of pediatric sepsis in southern China. A larger multicenter study should be performed to confirm these results.

Keywords: lncRNA CCAT2, sepsis, susceptibility, polymorphism

Introduction

Sepsis is a syndrome consisting of pathological, physiological and biochemical abnormalities caused by a dysfunctional response to infection and may cause life-threatening organ dysfunction.1 Studies have reported that the incidence of sepsis is increasing.2,3 Despite significant achievements in research and clinical practice, sepsis is the leading cause of death and critical illness worldwide.4 In addition, the incidence of sepsis in children is gradually increasing and is the main cause of death in neonates.5 In general, the severity of the inflammatory response is critical to the consequences of sepsis, and numerous studies have shown that genetic polymorphisms may have an impact on host immunity and susceptibility to sepsis as well as prognosis.6–8 Hence, genetic susceptibility genes might be used as biomarkers to assess susceptibility to sepsis.

Research shows that genetic polymorphisms are associated with susceptibility to multiple diseases, such as glioma, sepsis and diabetes.9–12 Long noncoding RNAs (lncRNAs), RNA molecules longer than 200 nucleotides that have no protein-coding potential,13 play an important role in a variety of pathological processes, such as cardiovascular diseases and inflammatory responses.14–16 Accumulating evidence also suggests that lncRNAs are important molecules involved in crosstalk with various pathways pertinent to innate immunity, mitochondrial functions, and apoptosis.17–19 Indeed, many studies have confirmed that lncRNAs play an important role in the process of innate immunity and apoptosis. It has been reported that noncoding RNA expression is dysregulated in patients with sepsis, and lncRNAs are considered good candidates for biomarkers and therapeutics for sepsis.17 For example, the lncRNA colon cancer-associated transcript 2 (CCAT2) is associated with a variety of diseases, including colon cancer and gastric cancer.20,21 Moreover, studies have confirmed that CCAT2 promotes MYC expression.20,22,23 Members of the myelodysplastic oncogene (MYC) family, including lung carcinoma-derived MYC (MYCL), cellular MYC (c-Myc) and neuroblastoma-derived MYC (MYCN), have an important oncogenic driver function in human cancers, and MYC family members also play an important regulatory role in the activation of immune cells.24 A number of studies have found that MYC participates in the pathogenesis of sepsis.25–27 Together, these findings suggest that CCAT2 may be involved in the pathology of sepsis. Recent studies have reported that CCAT2 gene polymorphisms are associated with susceptibility to various diseases, such as recurrent miscarriage, endometrial carcinoma and colorectal cancer,28–30and further research has shown that the rs6983267 polymorphism in the CCAT2 contributes to increases in MYC expression.22,31,32 Overall, the results of studies indicate that CCAT2 gene rs6983267 T > G may be associated with septic susceptibility. Nevertheless, the role of the CCAT2 gene rs6983267 T > G single-nucleotide polymorphism (SNP) in the development and progression of sepsis is still unclear. Therefore, in this study, we assessed the association of the rs6983267 T > G polymorphism in a population of patients with sepsis from South China that consisted of 474 cases and 678 controls.

Materials and Methods

Study Populations

We recruited 474 children with sepsis from the pediatric intensive care unit (PICU) and 678 age- and sex-matched healthy child controls who visited the hospital for medical examinations at the Guangzhou Women and Children Medical Center from January 2016 to December 2018. The diagnosis of sepsis was based on the international definition of sepsis, whereby sepsis is defined as the existence of possible or proven infection and whole-body performance of infection.33 The diagnostic criteria of organ dysfunction were according to Goldstein et al.34 The age- and sex-matched healthy child controls were randomly selected from the population undergoing health checkups at the hospital during the same period. No significant difference in age or sex was noted between the sepsis patients and healthy controls. According to the Declaration of Helsinki, this study was approved by the Ethics Committee of Guangzhou Women and Children Medical Center (The ethics number: 2015042202). Informed consent was obtained from the parent or legal guardian of all the patients and healthy controls.

SNP Selection and Genotyping

We collected 2 mL of venous whole blood from each patient; the peripheral blood samples were collected from the patients with sepsis within 24 hours after the diagnosis of sepsis. DNA was extracted from the whole blood (200 µL) of the healthy subjects and patients using a peripheral blood DNA extraction kit (Tiangen, Beijing, China). The yield and purity were measured using a NanoDrop2000 (Thermo Fisher Scientific, USA). The OD260/OD280 of the DNA extracted was between 1.6–1.8, and the purity met the requirements for the experiment. Genotyping was performed with real-time PCR and TaqMan allele discrimination assays. The CCAT2 (rs6983267) genotyping probe was purchased from ABI (Thermo Fisher Scientific, USA) (CCAT2 rs6983267 [C__29086771_20], Catalog number: 4351379, USA). SNP genotyping was performed using an ABI Q6 instrument (QuantStudioTM 6 Flex Real-Time PCR system, Thermo Fisher Scientific, USA). DNA amplification was performed in a volume of 5 μL containing 2.5 μL of TaqMan master mix (Tiangen, Beijing, China, catalog number: FP211), 1 μL of DNA (2.5 ng), 0.04 μL of primers, and 1.26 μL of H2O. SNP genotyping and amplification was performed in 384 wells using the TaqMan real-time polymerase chain reaction protocol. PCR was performed under the following conditions: preread stage, 60°C for 30 s; hold stage, 95°C for 10 min; PCR stage, 40 cycles at 95°C for 15 s and 60°C for 60 s; postread stage, 60°C for 30 s.

Statistical Analysis

Differences in sex, age, sepsis subtype, prognosis, number of organs with dysfunction, and genotype distribution between the case and healthy control groups were compared using the χ2 test. The SNP genotype distribution was assessed using the χ2 goodness of fit test to determine Hardy-Weinberg equilibrium (HWE) of the control subjects. The association of polymorphism with sepsis risk was examined by the odds ratio (OR), and the 95% confidence interval (95% CI) was determined by unconditional multivariate logistic regression analysis. Furthermore, unconditional logistic regression was used to adjust the OR and 95% CI based on age and sex. The method of calculating FPRP for all important findings was as described in the literature.35 We determined that the false positive report probability was 0.2; a prior probability of 0.1 was noteworthy. All statistical analyses were performed using SAS statistical analysis software (version 9.3; SAS Institute, Cary, NC, USA). All P values were bilateral, and a significance level of 0.05 was used in this study.

Results

General Characteristics

We recruited 474 patients with sepsis and 678 healthy controls who were 1 to 180 months and 1 to 168 months old, respectively (Table 1). No significant differences in age (35.04 ± 34.26 vs 35.53 ± 29.37 months, P = 0.1811) or sex (P = 0.111) were observed between the case and control groups. In sepsis patients, 74.39% had one or two organ dysfunctions, and 25.61% had three or more organ dysfunctions. The number of patients with sepsis and septic shock was 389 and 85, respectively, and 80 patients with sepsis eventually died. In this study, the main sources of infection in the patients were lung infection (58.65%), respiratory infection (3.8%), urinary tract infection (1.69%), brain infection (7.59%), abdominal infection (5.91%), primary bloodstream infection (7.38%) and others (14.98%).

Table 1 Frequency Distribution of Selected Characteristics in Sepsis Cases and Healthy Controls

Associations Between CCAT2 Gene Rs6983267 Polymorphisms and Sepsis in Children

To explore the relationship between the CCAT2 rs6983267 T> G polymorphism and susceptibility to childhood sepsis, we performed the χ2 goodness of fit test to evaluate whether the genotype frequency distribution of the control deviated from HWE (as shown in Table 2), and the results demonstrated that the control group was in HWE (P=0.5241). Single-locus analysis indicated that the rs6983267 T> G polymorphism was significantly associated with an increased risk of sepsis in children (TG and TT: adjusted OR = 1.311, 95% CI = 1.016–1.743, GG and TT: adjusted OR = 1.444, 95% CI = 1.025–2.034, dominant model: GG/TG vs TT adjusted OR = 1.362, 95% CI = 1.055–1.756). Our research results show that compared with the rs6983267 TT genotype, the GG/TG genotypes were significantly associated with an increased risk of sepsis in children.

Table 2 Genotype Frequency Distribution of CCAT2 in Sepsis Cases and Healthy Controls

Stratified Analysis

We further explored the association between the risk genotype of the CCAT2 rs6983267 T> G polymorphism and susceptibility to childhood sepsis in stratified analysis according to age, sex, sepsis subtype, prognosis, and number of organs with dysfunction (Table 3). Compared with the rs6983267 TT genotype, the risk effect of the TG/GG genotype was more pronounced in children younger than 60 months (adjusted OR = 1.376, 95% CI = 1.044–1.812, P = 0.0233), in males (adjusted OR = 1.463, 95% CI = 1.050–2.037, P = 0.0244) and in sepsis (adjusted OR = 1.311, 95% CI = 1.001–1.717, P = 0.0488). In addition, we observed an increased risk of death for TG/GG genotype carriers (adjusted OR = 2.011, 95% CI = 1.149–3.519, P = 0.0144) and an increased incidence of one or two organs at risk of dysfunction (adjusted OR = 1.445, 95% CI = 1.060–1.969, P = 0.0199).

Table 3 Stratification Analysis of Susceptibility in Sepsis Patients

FPRP values for the CCAT2 gene are shown in Table 4. Most of the significant findings in this analysis disappeared when the FPRP value was 0.2 and the prior probability was 0.1. Moreover, the effect of the rs6983267 GG/TG genotypes (FPRP = 0.143) on the increased risk of sepsis in children remained credible compared to that of the rs6983267 TT genotype. Regarding stratification analyses, the association between the GG/TG genotypes and the increased risk of sepsis in children younger than 60 months (FPRP = 0.196) and the increased incidence of one or two organs at risk of dysfunction (FPRP = 0.191) were still noteworthy. However, most of the significant findings in the FPRP analysis disappeared, possibly due to the limited sample size, especially for subgroups. Therefore, the important findings from the current research need to be verified in a large-sample prospective study.

Table 4 False Positive Report Probability Values for Associations Between the Risk of Sepsis and CCAT2 Polymorphism Genotype

Discussion

In our case-control study of 474 children with sepsis and 678 healthy controls, we found that the CCAT2 rs6983267 TG/GG genotypes were associated with an increased risk of sepsis in children. Furthermore, the risk effect was more pronounced in children younger than 60 months, in those who were male, and in those who had sepsis. To the best of our knowledge, this is the first study to investigate the relationship between CCAT2 (rs6983267 T> G) gene polymorphism and susceptibility to sepsis in children in southern China.

A growing number of studies have found that the CCAT2 polymorphism rs6983267 T> G is associated with susceptibility to a variety of diseases. For instance, Sahasrabudhe R et al reported that the rs6983267 G variant is associated with increased thyroid cancer risk,36 and Zhao X et al suggested that the rs6983267 genotype correlated significantly with endometrial carcinoma susceptibility and lymph node metastasis.29 Moreover, the results of a study by Che D et al indicated that the rs6983267 G allele may help reduce the risk of recurrent miscarriage in a population from South China.28 In our study, the lncRNA CCAT2 rs6983267 G variant was associated with an increased risk of sepsis in children. In general, gene polymorphisms vary among populations. For example, Monir Sadat Haerian et al reported that the CCAT2 gene rs6983267 polymorphisms was not relevant to colorectal cancer risk in an Iranian population,37 though the CCAT2 rs6983267 TT genotype is slightly more prevalent in colorectal cancer patients than the GG genotype.38 A study by Keum Ji Jung et al found that CCAT2 rs6983267 was associated with an increased risk of colorectal cancer in a Korean population.39 Nevertheless, there is no research to date on CCAT2 gene polymorphisms and genetic susceptibility to sepsis. Indeed, our study is the first to examine the relationship between CCAT2 gene polymorphism and genetic susceptibility to sepsis in a population from southern China. It should be noted that our research results need to be verified in other ethnic groups with different genetic backgrounds.

Olfat G Shaker et al reported that rs6983267 is a potential genetic marker of colorectal cancer and correlates with serum CCAT2 in Egyptian patients,30 and it may be involved in disease susceptibility by regulating expression of the lncRNA. Nonetheless, the molecular mechanism remains unclear, and further research is needed. Studies have confirmed that MYC has key functions in mediating inflammation and immune suppression;40,41 the inflammatory response is crucial to the pathological process of sepsis, which leads to prolonged inflammation, insurmountable infection and, ultimately, death.42 Liu L et al reported that MYC dependence and HIF1α dependence play an important supporting role in the regulation of the inflammatory response process.27 Zhang Y et al found that MCP-induced protein 1 regulates macrophage polarization via the JNK/c-MYC pathway to attenuate sepsis-induced acute lung injury,25 and Lazniak S et al reported that rs6983267 in the lncRNA CCAT2 gene may contribute to increased MYC expression.22 According to Takatsuno Y et al, by upregulating MYC transcription, the rs6983267 polymorphism is associated with a worse prognosis in colorectal cancer patients.43 Pomerantz MM et al revealed that the risk region of CCAT2 gene rs6983267 physically interacts with the MYC proto-oncogene.44 Because our study was retrospective, we only collected whole blood samples for SNP analysis, and we did not detect MYC expression levels in patients with sepsis. Regardless, all data suggest that CCAT2 rs6983267 may participate in the pathological process of sepsis by regulating MYC. Of course, this hypothesis requires additional experiments for confirmation.

Studies have also found that genetic polymorphisms are related to the severity and prognosis of sepsis. Mansur A et al reported that rs11536889 in the Toll-like receptor 4 gene is associated with renal and hepatic organ failure in sepsis patients and may be a useful marker of organ failure in these patients.45 The study of Chen K et al revealed that a functional Toll-like receptor variant (4/2242 polymorphism) is associated with multiple organ dysfunction scores and higher sepsis morbidity in patients with major trauma.46 It has been estimated that infection is responsible for the vast majority of death in children under 60 months (nearly 60%).47 In our study, the CCAT2 rs6983267 GT/GG genotypes correlated with a significantly increased risk of sepsis in children younger than 60 months, in males, and in those who had sepsis. However, the molecular mechanism requires further study.

Some limitations of this study should be noted. First, the sample size was relatively small, especially with regard to the stratified analysis. For instance, for nonsurvivors, there were only 17 samples, and we calculated a highly significant P-value of 0.0088. This is an extremely small sample size for genetic studies. The statistical power in this study was limited by the sample size, and our results need to be confirmed in a larger, multicenter study. Second, we focused only on the relationship between the CCAT2 rs6983267 T>G polymorphism and susceptibility to childhood sepsis, and more SNPs need to be included in the future. Third, we included only children in southern China, and as this study was retrospective, some important information (eg, parental exposure) was not collected. Due to differences in the genetic backgrounds and environmental exposures of different ethnicities, our findings should be cross-validated in different populations.

In conclusion, we found that the CCAT2 gene rs6983267 T > G polymorphism may be associated with an increased risk of sepsis in children in southern China, especially in males younger than 60 months old and in those with sepsis. However, a larger multicenter study should be performed to confirm the role of CCAT2 polymorphism in susceptibility to sepsis in children, and further research is needed to elucidate the regulatory mechanism of CCAT2 in pediatric sepsis.

Data Sharing Statement

Please contact the Correspondence author (Xiaoqiong Gu) for data requests.

Acknowledgments

We appreciate all the patients and individuals for their participation in this study. We would to thank the Clinical Biological Resource Bank of Guangzhou Women and Children’s Medical Center for providing all the clinical samples.

Author Contributions

All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; agreed to submit to the current journal; gave final approval of the version to be published; and agree to be accountable for all aspects of the work.

Funding

This study was funded by the Guangzhou Science and Technology Program Project, China (grant numbers 201904010486, 202102010197), the Guangdong Natural Science Fund, China (grant numbers 2021A1515011207, 2019A1515012061), and the Guangzhou Institute of Pediatrics/Guangzhou Women and Children’s Medical Center Fund, China (Grant Number: GCP-2019-006, GCP-2019-003).

Disclosure

The authors declare that they have no conflicts of interest to report.

References

1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–810. doi:10.1001/jama.2016.0287

2. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60(6):1070–1077. doi:10.1111/j.1532-5415.2012.03989.x

3. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–1174. doi:10.1097/CCM.0b013e31827c09f8

4. Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2:380–386. doi:10.1016/S2213-2600(14)70061-X

5. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8. doi:10.1097/01.PCC.0000149131.72248.E6

6. Jabandziev P, Smerek M, Michalek J, Fedora M, Kosinova L. Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsis. Critical Care. 2014;18:R1. doi:10.1186/cc13174

7. Cernada M, Serna E, Bauerl C, Collado MC, Perez-Martinez G, Vento M. Genome-wide expression profiles in very low birth weight infants with neonatal sepsis. Pediatrics. 2014;133(5):e1203–11. doi:10.1542/peds.2013-2552

8. Liu C, Jin P, Luo Y, et al. Association of Single-Nucleotide Polymorphisms of C-Reactive Protein Gene with Susceptibility to Infantile Sepsis in Southern China. Med Sci Monitor. 2018;24:590–595. doi:10.12659/MSM.908602

9. Yao L, Zhou L, Deng Y, et al. Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: a Case-Control Study. Onco Targets Ther. 2019;12:8241–8247. doi:10.2147/OTT.S221204

10. Varljen T, Sekulovic G, Rakic O, et al. Genetic variant rs16944 in IL1B gene is a risk factor for early-onset sepsis susceptibility and outcome in preterm infants. Inflamm Res. 2019;69(2):155–157. doi:10.1007/s00011-019-01301-4

11. Witka BZ, Oktaviani DJ, Marcellino M, Barliana MI, Abdulah R. Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors. Diabetes Metab Syndr Obes. 2019;12:2689–2706. doi:10.2147/DMSO.S230061

12. Wu Y, Zhou L, Deng Y, et al. The polymorphisms (rs3213801 and rs5744533) of DNA polymerase kappa gene are not related with glioma risk and prognosis: a case-control study. Cancer Med. 2019;8(17):7446–7453. doi:10.1002/cam4.2566

13. Castellanos-Rubio A, Ghosh S. Disease-Associated SNPs in Inflammation-Related lncRNAs. Front Immunol. 2019;10:420. doi:10.3389/fimmu.2019.00420

14. Mathy NW, Chen XM. Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses. J Biol Chem. 2017;292:12375–12382. doi:10.1074/jbc.R116.760884

15. Bhan A, Soleimani M, Mandal SS. Long Noncoding RNA and Cancer: a New Paradigm. Cancer Res. 2017;77(15):3965–3981. doi:10.1158/0008-5472.CAN-16-2634

16. Li M, Duan L, Li Y, Liu B. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases. Life Sci. 2019.

17. Ho J, Chan H, Wong SH, et al. The involvement of regulatory non-coding RNAs in sepsis: a systematic review. Critical Care. 2016;20:383. doi:10.1186/s13054-016-1555-3

18. Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423–437.

19. Zheng D, Yu Y, Li M, et al. Inhibition of MicroRNA 195 Prevents Apoptosis and Multiple-Organ Injury in Mouse Models of Sepsis. J Infect Dis. 2016;213:1661–1670. doi:10.1093/infdis/jiv760

20. Ling H, Spizzo R, Atlasi Y. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446–1461. doi:10.1101/gr.152942.112

21. Wang CY, Hua L, Yao KH, Chen JT. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015;8:779–785.

22. Lazniak S, Lutkowska A, Warenczak-Florczak Z, Sowinska A, Tsibulski A, Roszak A. The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population. Arch Gynecol Obstet. 2018;297:1285–1292. doi:10.1007/s00404-018-4740-6

23. Yan L, Wu X, Yin X, Du F, Liu Y, Ding X. LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion. J Cell Mol Med. 2018;22:2592–2599. doi:10.1111/jcmm.13518

24. Gnanaprakasam JN, Wang R. MYC in Regulating Immunity: metabolism and Beyond. Genes. 2017;8. doi:10.3390/genes8030088

25. Zhang Y, Huang T, Jiang L, et al. MCP-induced protein 1 attenuates sepsis-induced acute lung injury by modulating macrophage polarization via the JNK/c-Myc pathway. Int Immunopharmacol. 2019;75:105741. doi:10.1016/j.intimp.2019.105741

26. Li Y, Zhang F, Cong Y, Zhao Y. Identification of potential genes and miRNAs associated with sepsis based on microarray analysis. Mol Med Rep. 2018;17:6227–6234. doi:10.3892/mmr.2018.8668

27. Liu L, Lu Y, Martinez J, et al. Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1alpha-dependent. Proc Natl Acad Sci U S A. 2016;113:1564–1569. doi:10.1073/pnas.1518000113

28. Che D, Huang W, Fang Z, et al. The lncRNA CCAT2 rs6983267 G allele is associated with decreased susceptibility to recurrent miscarriage. J Cell Physiol. 2019;234:20577–20583. doi:10.1002/jcp.28661

29. Zhao X, Wei X, Zhao L, et al. The rs6983267 SNP and long non-coding RNA CARLo-5 are associated with endometrial carcinoma. Environ Mol Mutagen. 2016;57:508–515. doi:10.1002/em.22031

30. Shaker OG, Senousy MA, Elbaz EM. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients. Sci Rep. 2017;7(1):16246. doi:10.1038/s41598-017-16500-4

31. Kim J, Lee J, Oh JH, et al. Associations among dietary seaweed intake, c-MYC rs6983267 polymorphism, and risk of colorectal cancer in a Korean population: a case-control study. Eur J Nutr. 2019;58(8):3255–3266. doi:10.1007/s00394-018-1868-x

32. Gong J, Tian J, Lou J, et al. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267. Ann Oncol. 2018;29:632–639. doi:10.1093/annonc/mdx789

33. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228.

34. Watson RS, Crow SS, Hartman ME, Lacroix J, Odetola FO. Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome. Pediatr Crit Care Med. 2017;18:S4–S16. doi:10.1097/PCC.0000000000001047

35. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434–442. doi:10.1093/jnci/djh075

36. Sahasrabudhe R, Estrada A, Lott P, et al. The 8q24 rs6983267G variant is associated with increased thyroid cancer risk. Endocr Relat Cancer. 2015;22:841–849. doi:10.1530/ERC-15-0081

37. Haerian MS, Haerian BS, Rooki H, et al. Association of 8q24.21 rs10505477-rs6983267 haplotype and age at diagnosis of colorectal cancer. Asian Pacific j Cancer Prevent. 2014;15:369–374. doi:10.7314/APJCP.2014.15.1.369

38. Kasagi Y, Oki E, Ando K, et al. The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers. Oncology. 2017;92:48–54. doi:10.1159/000452143

39. Jung KJ, Kim MT, Jee SH. Impaired fasting glucose, single-nucleotide polymorphisms, and risk for colorectal cancer in Koreans. Epidemiol Health. 2016;38:e2016002. doi:10.4178/epih.e2016002

40. Kortlever RM, Sodir NM, Wilson CH, Burkhart DL, Pellegrinet L, Brown Swigart L. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171(1301–1315):e14. doi:10.1016/j.cell.2017.11.013

41. Liu T, Zhou Y, Ko KS, Yang H. Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases. Mediators Inflamm. 2015;2015:276850. doi:10.1155/2015/276850

42. Delano MJ, Ward PA. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274:330–353. doi:10.1111/imr.12499

43. Takatsuno Y, Mimori K, Yamamoto K, et al. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer. Ann Surg Oncol. 2013;20:1395–1402. doi:10.1245/s10434-012-2657-z

44. Pomerantz MM, Ahmadiyeh N, Jia L, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet. 2009;41:882–884. doi:10.1038/ng.403

45. Mansur A, von Gruben L, Popov AF, et al. The regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients. J Transl Med. 2014;12:177. doi:10.1186/1479-5876-12-177

46. Chen K, Wang YT, Gu W, et al. Functional significance of the Toll-like receptor 4 promoter gene polymorphisms in the Chinese Han population. Crit Care Med. 2010;38:1292–1299. doi:10.1097/CCM.0b013e3181d8ad12

47. Emr BM, Alcamo AM, Carcillo JA, Aneja RK, Mollen KP. Pediatric Sepsis Update: how Are Children Different? Surg Infect (Larchmt). 2018;19:176–183. doi:10.1089/sur.2017.316

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.